Please assess the completion status of the following clinical trial:

Trial Title: Effect of Deep BLock on Intraoperative Surgical Conditions

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients diagnosed with renal or prostatic disease who are will undergo an elective laparoscopic renal surgical procedure or laparoscopic prostatectomy;~* ASA class I-III~* \> 18 years of age;~* Ability to give oral and written informed consent~Exclusion Criteria:~* Known or suspected neuromuscular disorders impairing neuromuscular function;~* Allergies to muscle relaxants, anesthetics or narcotics;~* A (family) history of malignant hyperthermia;~* Patients who have a contraindication for neostigmine administration;~* Women who are or may be pregnant or are currently breast feeding;~* Renal insufficiency, as defined by serum creatinine x 2 of normal, or urine output \< 0.5 ml/kg/h for at least 6 h. When available, other indices will be taken into account as well such as glomerular filtration rate \< 60 ml/h and proteinuria (a ratio of 30 mg albumin to 1 g of creatinine).~* Previous retroperitoneal surgery at the site of the current surgery.~* Body mass index \> 35 kg/m2

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Deep surgical block (Type: EXPERIMENTAL): Continuous rocuronium infusion will be used to induce a deep surgical block with post tetanic twitch count of max 2. Rocuronium loading dose = 1.0 mg/kg, followed by 0.6-1.0 mg/kg per hour.
- Moderate/normal surgical block (Type: ACTIVE_COMPARATOR): A normal block will be induced by an atracurium bolus dose followed by a mivacurium infusion to induce a train of four count of 1-2.

Based on this trial design, predict the completion outcome and termination type (if applicable).